We need to know the risk of your breast cancer recurring

If you have been diagnosed with breast cancer (ER+ or ER- with up to 3 positive nodes) MammaPrint helps your physician make the best-informed decisions to determine your optimal treatment regime.

If there is a low risk of your cancer recurring, you may be able to avoid adjuvant therapy, and the toxicity and other side-effects often associated with such treatment.

Using the latest molecular diagnostic tools, MammaPrint provides a clear risk assessment – delivering your test results within 10 working days.

• MammaPrint assesses clearly the individual risk of breast cancer recurrence
• MammaPrint provides valuable information to decide on the right treatment
• MammaPrint is cleared by the FDA and has been proven in more than 12,000 tests
• MammaPrint means no additional invasive procedures

MammaPrint Patients Video

This video shows general information about the MammaPrint technology and its advantages for patients.

Download brochures